Health
Testing times: More work needed on AstraZeneca-Oxford vaccine trials – Sydney Morning Herald
AstraZeneca and Oxford University have more work to do to confirm whether their COVID-19 vaccine can be 90 per cent effective, peer-reviewed data published in The…
“(This) will require further research as more data becomes available from the trial,” the study said.
Less than 6 per cent of UK trial participants were given the lower dose regimen and none of them was aged over 55, meaning more research will be needed to investigate the vaccine’s efficacy in older people who are particularly susceptible to COVID-19.
Pooling the results, overall efficacy was 70.4 per cent, the data on Tuesday showed. That is above the 50 per cent minimum set by the US Food and…
-
Business19 hours ago3 ASX ETFs to generate passive income in retirement
-
General17 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News14 hours agoAlternative pathways to university explained
-
Noosa News19 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
